| Ipilimumab and gemcitabine for advanced pancreatic cancer: a phase Ib study SD Kamath, A Kalyan, S Kircher, H Nimeiri, AJ Fought, A Benson III, ... The oncologist 25 (5), e808-e815, 2020 | 149 | 2020 |
| Long-term gemcitabine treatment reshapes the pancreatic tumor microenvironment and sensitizes murine carcinoma to combination immunotherapy DR Principe, M Narbutis, S Kumar, A Park, N Viswakarma, MJ Dorman, ... Cancer research 80 (15), 3101-3115, 2020 | 100 | 2020 |
| Immune checkpoint inhibitors for the treatment of central nervous system (CNS) metastatic disease SD Kamath, PU Kumthekar Frontiers in oncology 8, 414, 2018 | 92 | 2018 |
| FGFR3–TACC3: a novel gene fusion in cervical cancer BA Carneiro, JA Elvin, SD Kamath, SM Ali, AS Paintal, A Restrepo, ... Gynecologic oncology reports 13, 53-56, 2015 | 71 | 2015 |
| Trials and tribulations of pancreatic cancer immunotherapy DR Principe, M Korc, SD Kamath, HG Munshi, A Rana Cancer letters 504, 1-14, 2021 | 55 | 2021 |
| LBA12 Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma … A Hollebecque, M Borad, L Goyal, A Schram, JO Park, PA Cassier, ... Annals of Oncology 33, S1381, 2022 | 45 | 2022 |
| Comparison of cancer burden and nonprofit organization funding reveals disparities in funding across cancer types SD Kamath, SM Kircher, AB Benson Journal of the National Comprehensive Cancer Network 17 (7), 849-854, 2019 | 44 | 2019 |
| RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations V Subbiah, V Sahai, D Maglic, K Bruderek, BB Touré, S Zhao, R Valverde, ... Cancer discovery 13 (9), 2012-2031, 2023 | 42 | 2023 |
| The immune modifying effects of chemotherapy and advances in chemo-immunotherapy DR Principe, SD Kamath, M Korc, HG Munshi Pharmacology & therapeutics 236, 108111, 2022 | 42 | 2022 |
| Esophageal adenocarcinoma: A dire need for early detection and treatment A Joseph, S Raja, S Kamath, S Jang, D Allende, M McNamara, G Videtic, ... Cleveland Clinic Journal of Medicine 89 (5), 269-279, 2022 | 42 | 2022 |
| Survivorship guidance for patients with colorectal cancer J Simard, S Kamath, S Kircher Current treatment options in oncology 20, 1-15, 2019 | 39 | 2019 |
| DPYD Testing: Time to Put Patient Safety First SD Baker, SE Bates, GA Brooks, WL Dahut, RB Diasio, WS El-Deiry, ... Journal of Clinical Oncology 41 (15), 2701-2705, 2023 | 36 | 2023 |
| Outcomes for endoscopic submucosal dissection of pathologically staged T1b esophageal cancer: a multicenter study A Joseph, PV Draganov, F Maluf-Filho, H Aihara, N Fukami, NR Sharma, ... Gastrointestinal endoscopy 96 (3), 445-453, 2022 | 31 | 2022 |
| Disruption of NO-cGMP signaling by neonatal hyperoxia impairs relaxation of lung parenchyma RB Sopi, MA Haxhiu, RJ Martin, IA Dreshaj, S Kamath, SIA Zaidi American Journal of Physiology-Lung Cellular and Molecular Physiology 293 (4 …, 2007 | 30 | 2007 |
| Racial disparities negatively impact outcomes in early‐onset colorectal cancer independent of socioeconomic status SD Kamath, N Torrejon, W Wei, K Tullio, KG Nair, D Liska, ... Cancer Medicine 10 (21), 7542-7550, 2021 | 28 | 2021 |
| XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer DR Principe, R Xiong, Y Li, TND Pham, SD Kamath, O Dubrovskyi, ... Proceedings of the National Academy of Sciences 119 (4), e2116764119, 2022 | 27 | 2022 |
| Pembrolizumab for the treatment of gastric cancer SD Kamath, A Kalyan, AB Benson III Expert review of anticancer therapy 18 (12), 1177-1187, 2018 | 27 | 2018 |
| Updated dose escalation results for ReFocus, a first-in-human study of highly selective FGFR2 inhibitor RLY-4008 in cholangiocarcinoma and other solid tumors MJ Borad, AM Schram, RD Kim, SD Kamath, V Sahai, E Dotan, RK Kelley, ... J Clin Oncol 41 (suppl 16), 4009, 2023 | 18 | 2023 |
| Multidisciplinary evaluation and management of early stage esophageal cancer A Bhatt, S Kamath, SC Murthy, S Raja Surgical Oncology Clinics 29 (4), 613-630, 2020 | 17 | 2020 |
| Staphylococcus epidermidis Protection Against Staphylococcus aureus Colonization in People Living With Human Immunodeficiency Virus in an Inner-City … SB Sullivan, S Kamath, TH McConville, BT Gray, FD Lowy, PG Gordon, ... Open Forum Infectious Diseases 3 (4), ofw234, 2016 | 17 | 2016 |
Alok A. KhoranaHardis Endowed Chair in Onc Research, Vice-Chair, Taussig Cancer Ctr, Director, GI CancersGeverifieerd e-mailadres voor ccf.org
